Skip to content

Sara K. Meibom, MD

NPI 1972688349ActiveIndividual· Nuclear Medicine· Boston, MA

Nuclear Medicine (MD) in Boston, Massachusetts, trained at University of Wisconsin School of Medicine (class of 1998). Medicare paid $40,410 for services to 387 patients in 2024. Progenics Pharmaceuticals, Inc. was the largest of 2 companies reporting payments in 2025, $44.33 in all, mostly food and beverage.

Overview

NPI1972688349
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedOct 26, 2006
Last updated in NPPESMar 9, 2026
Certified by providerMar 9, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Nuclear Medicine Primary207U00000X228923MA
Nuclear Medicine, Nuclear Cardiology207UN0901X228923MA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Nuclear Medicine (MA)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients387
Services billed618 across 36 procedure codes
Paid by Medicare$40,410

Medicare sources and data years

Education and affiliations

Medical schoolUniversity of Wisconsin School of Medicine
Graduation year1998
Medicare specialtyNuclear Medicine

Medical group

Hospital affiliation

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$44.33 · 2 payments from 2 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$44.33 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Nuclear Medicine providers in Boston

All 19 Nuclear Medicine providers in Boston · All Nuclear Medicine providers in Massachusetts